SCHEMBL7224474

SCHEMBL7224474

CC(C)CC(S)[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7230094 1.00
SCHEMBL4300072 0.71 ENPEP (0.32)
SCHEMBL29369773 0.71
SCHEMBL7910161 0.69 ALDH1A1 (0.35)
SCHEMBL270873 0.69
SCHEMBL5503133 0.69
SCHEMBL16927544 0.67
SCHEMBL7221591 0.66
SCHEMBL934967 0.66
SCHEMBL26092785 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6613782-B2 For treating and/or preventing endothelin dependent conditions, e.g. cardio- and cerebro-vascular disorders such as hypertension, vasoconstriction, congestive heart failure, cerebral disorders, respiratory system disorders NOVARTIS AG (CH) 2003-09-02 US disclosed
US-6423727-B1 Certain thiol inhibitors of endothelin-converting enzyme NOVARTIS AG (CH) 2002-07-23 US disclosed
US-20020082218-A1 Certain thiol inhibitors of endothelin-converting enzyme LOMBAERT STEPHANE DE (US) 2002-06-27 US disclosed
EP-1073674-A1 THIOL INHIBITORS OF ENDOTHELIN-CONVERTING ENZYME Novartis AG (CH) 2001-02-07 EP disclosed
WO-1999055726-A1 CERTAIN THIOL INHIBITORS OF ENDOTHELIN-CONVERTING ENZYME NOVARTIS AG (CH) 1999-11-04 WO disclosed
US-5843753-A Metalloprotease having increased activity NOVO NORDISK A/S (DK) 1998-12-01 US disclosed
US-5807729-A ISOLATED NUCLEIC ACID NOVO NORDISK A/S (DK) 1998-09-15 US disclosed
US-5691162-A OBTAINED FROM FUNGUS NOVO NORDISK A/S (DK) 1997-11-25 US disclosed